Literature DB >> 18390731

A conserved IFN-alpha receptor tyrosine motif directs the biological response to type I IFNs.

Wenli Zhao1, Carolyn Lee, Rebecca Piganis, Courtney Plumlee, Nicole de Weerd, Paul J Hertzog, Christian Schindler.   

Abstract

Mammalian type I IFNs (IFN-Is) mediate their potent biological activities through an evolutionarily conserved IFN-alpha receptor (IFNAR), consisting of IFNAR1 and IFNAR2. These two chains direct the rapid activation of two founding members of the STAT family of transcription factors, STAT1 and STAT2. To understand how IFN-Is direct the recruitment and activation of STATs, a series of mutant murine IFNAR1 and IFNAR2 receptors were generated and evaluated in IFNAR1 and IFNAR2 knockout cells. These studies reveal that a single conserved IFNAR2 tyrosine, Y(510), plays a critical role in directing the IFN-I-dependent activation of STAT1 and STAT2, both in murine fibroblasts and macrophages. A second IFNAR2 tyrosine, Y(335), plays a more minor role. Likewise, Y(510) > Y(335) play a critical role in the induction of genes and antiviral activity traditionally associated with IFN-Is.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18390731     DOI: 10.4049/jimmunol.180.8.5483

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.

Authors:  Rebecca A R Piganis; Nicole A De Weerd; Jodee A Gould; Christian W Schindler; Ashley Mansell; Sandra E Nicholson; Paul J Hertzog
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

2.  Interferons direct an effective innate response to Legionella pneumophila infection.

Authors:  Courtney R Plumlee; Carolyn Lee; Amer A Beg; Thomas Decker; Howard A Shuman; Christian Schindler
Journal:  J Biol Chem       Date:  2009-08-31       Impact factor: 5.157

3.  Receptor density is key to the alpha2/beta interferon differential activities.

Authors:  Ignacio Moraga; Daniel Harari; Gideon Schreiber; Gilles Uzé; Sandra Pellegrini
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

4.  Kinetics of cytokine receptor trafficking determine signaling and functional selectivity.

Authors:  Jonathan Martinez-Fabregas; Stephan Wilmes; Luopin Wang; Majid Kazemian; Suman Mitra; Ignacio Moraga; Maximillian Hafer; Elizabeth Pohler; Juliane Lokau; Christoph Garbers; Adeline Cozzani; Paul K Fyfe; Jacob Piehler
Journal:  Elife       Date:  2019-11-27       Impact factor: 8.140

5.  A hot spot on interferon α/β receptor subunit 1 (IFNAR1) underpins its interaction with interferon-β and dictates signaling.

Authors:  Nicole A de Weerd; Antony Y Matthews; Phillip R Pattie; Nollaig M Bourke; San S Lim; Julian P Vivian; Jamie Rossjohn; Paul J Hertzog
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

6.  Type I Interferon acts as a major barrier to the establishment of infectious bursal disease virus (IBDV) persistent infections.

Authors:  Laura Broto; Nicolás Romero; Fernando Méndez; Elisabet Diaz-Beneitez; Oscar Candelas-Rivera; Daniel Fuentes; Liliana L Cubas-Gaona; Céline Courtillon; Nicolas Eterradossi; Sébastien M Soubies; Juan R Rodríguez; Dolores Rodríguez; José F Rodríguez
Journal:  J Virol       Date:  2020-12-16       Impact factor: 5.103

7.  Functional crosstalk between type I and II interferon through the regulated expression of STAT1.

Authors:  Daniel J Gough; Nicole L Messina; Linda Hii; Jodee A Gould; Kanaga Sabapathy; Ashley P S Robertson; Joseph A Trapani; David E Levy; Paul J Hertzog; Christopher J P Clarke; Ricky W Johnstone
Journal:  PLoS Biol       Date:  2010-04-27       Impact factor: 8.029

8.  Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1.

Authors:  Nicole A de Weerd; Julian P Vivian; Thao K Nguyen; Niamh E Mangan; Jodee A Gould; Susie-Jane Braniff; Leyla Zaker-Tabrizi; Ka Yee Fung; Samuel C Forster; Travis Beddoe; Hugh H Reid; Jamie Rossjohn; Paul J Hertzog
Journal:  Nat Immunol       Date:  2013-07-21       Impact factor: 25.606

9.  Dual modulation of type I interferon response by bluetongue virus.

Authors:  Virginie Doceul; Emilie Chauveau; Estelle Lara; Emmanuel Bréard; Corinne Sailleau; Stéphan Zientara; Damien Vitour
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

10.  Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapies.

Authors:  Christopher J Carbone; Hui Zheng; Sabyasachi Bhattacharya; John R Lewis; Alexander M Reiter; Paula Henthorn; Zhong-Yin Zhang; Darren P Baker; Radha Ukkiramapandian; Kendra K Bence; Serge Y Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.